2m 2m 2m 2m 2m 2m 2m
AKANDA (AKAN)
NASDAQ
$3.87+$0.008 (+0.21%)
Price as of Aug 21, 2026 7:59 PM EDT- $2.1MMarket Cap
- -95.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AKANDA (AKAN)
$3.87+$0.008 (+0.21%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 39
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$3.77
$4.00
$3.86
1-Year Range
$0.45
$57.09
$3.86
Latest Close$3.86
Change
-$0.04 (-1.04%)
Volume164,811
Market Cap$2.1M
Shares Outstanding540,841
P/E (TTM)-0.0003
Diluted EPS (TTM)-$14,899.95
Enterprise Value$2.7M
Information as of 08/21/2026
Company Profile
AKANDA CORP
https://www.akandacorp.com$2.1M
Market Cap
-$45.7M
Net Income
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
100 King St. W, Toronto, ON, Canada, M5X 1G5
416 862 7525Akanda Corp., through its subsidiaries, operates as early-stage cannabis company in Mexico. It is involved in medical cannabis cultivation, manufacturing, and sale; and leasing and/or rental of fiber optic networks and telecommunication towers. The company is based in Toronto, Canada.
Key Executives
- Katharyn Field
- Edgar Contreras
- Gurcharn Deol
- Francisco Juarez
Current Ownership Distribution
- Mutual Funds725,529 (50.72%)
- Institutions697,158 (48.74%)
- Insiders7,816 (0.55%)
- Other0 (0.00%)